{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-030886","form_type":"8-K","ticker":"MRAI","cik":"0001844392","company_name":"Marpai, Inc.","filed_at":"2023-06-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:41.157929+00:00","generated_at":"2026-06-13T14:20:37.755967+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Marpai confirms Q2 2023 revenue guidance of $9.5M-$9.8M; expects EBITDA improvement","bullets":["Preliminary Q2 2023 revenue between $9.5M and $9.8M.","Expects sequential improvement in EBITDA and net income vs Q1 2023.","Progress on Maestro Health integration and cost-cutting cited for improved profitability.","Revenue roughly flat sequentially as previously anticipated."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-030886","json":"https://secwatch.observer/filing/0000950170-23-030886.json","markdown":"https://secwatch.observer/filing/0000950170-23-030886.md","text":"https://secwatch.observer/filing/0000950170-23-030886.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023030886/0000950170-23-030886-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023030886/mrai-20230629.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-13T14:20:37.755967+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"878bd65cb4e424d089b53100b6e33305a626e15f","claim":"Marpai, Inc. reported Q2 2023 results: revenue $9.5 million to $9.8 million. Guidance reaffirmed.","evidence_excerpt":"Marpai Confirms Revenue Guidance for Q2 2023 of $9.5 Million to $9.8 Million Company cites expected improvements in EBITDA NEW YORK—( BUSINESS WIRE )— Marpai, Inc .—June 29, 2023—(\"Marpai\" or the \"Company\") (Nasdaq: MRAI), an AI-powered Third-Party Administrator (TPA) transforming self-funded employer health plans, confirmed its revenue guidance for Q2 2023 as between $9.5 million to $9.8 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1844392/000095017023030886/0000950170-23-030886-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"Q2 2023"},{"label":"Revenue","value":"$9.5 million to $9.8 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}